UCSF

Tagged: Chemistry and Chemical Biology Graduate Program (CCB)

Gartner named one of Popular Science’s “Brilliant 10” of 2015

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is...

UCSF-Amgen Symposium

The UCSF School of Pharmacy Industry Outreach Program presents a UCSF-Amgen Symposium.

This event will comprise two sessions:

Antibody Network partners with Celgene to develop cancer therapies

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies.

UCSF School of Pharmacy leads in NIH funding for 35th year in a row

For the 35th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $31.8 million during the 2014 fiscal year, from October 1, 2013 to September 30,...

DeGrado receives Protein Society’s Stein and Moore Award

William DeGrado, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry, has been named the 2015 recipient of The Protein Society’s Stein and Moore Award.

Huang advances to tenured position as associate professor

Bo Huang, PhD, has received tenure and advanced to the position of associate professor. He is a faculty member in the Department of Pharmaceutical Chemistry, and he holds a joint appointment in the Department of Biochemistry and Biophysics.

Most recent School of Pharmacy primary faculty hires, by department

The most recently hired faculty members to join the UCSF School of Pharmacy have research interests that range from the treatment of blood clots to mapping biological networks in cancer cells to understanding the molecular workings of ion channels in cell membranes. But they all share the common...

Desai Lab develops nanodevices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Andrew Braisted Lecture

This endowed lecture was established by UCSF and UC Berkeley to bring together San Francisco Bay Area scientists who work at the interface of chemistry and biology. The lecture was established in memory of Andrew Braisted, a young scientist in chemical biology who had strong ties to UCSF, UCB, and...

Pages